In silico phenotypic screening that predicts how compounds perform in cells
Reflector Bio is a New York techbio company building a biological foundation model for AI drug discovery that predicts a compound's efficacy, function and safety signals in living cells, complementing structure-based binding tools. The model is trained on lab data from millions of experiments and tailored to each client's program to help biopharma teams prioritise compounds and experiments. It emerged from stealth in October 2026. Founder and CEO Yuge Ji is an MIT-trained computational biologist who previously built drug discovery models at Flagship Pioneering's Cellarity.
For people
For agents
Nothing listed yet.